Biomarker predicts recovery from a type of depression

Biomarker predicts recovery from a type of depression

People who live with clinical depression must also suffer the ‘trial and error’ approach that psychiatrists take when prescribing antidepressants. A new study signifies the beginning of the end of guess-work. In it, a blood test predicts who responds well to a novel treatment for depression, and who might even fair worse.  Read more

Epigenetic drug may lower cholesterol build-up

Epigenetic drug may lower cholesterol build-up

With a market worth more than US$20.1 billion, drug companies have long competed in a race to develop cholesterol medicines that work better than statins. Today, researchers report on a little-known alternative – an epigenetic therapy that fights plaque-hardened arteries in a novel manner.  Read more

Digital pills make their way to market

Digital pills make their way to market

Digestible microchips embedded in drugs may soon tell doctors whether a patient is taking their medications as prescribed. These sensors are the first ingestible devices approved by the US Food and Drug Administration (FDA). To some, they signify the beginning of an era in digital medicine.  Read more

World Bank debate on paying for AIDS

World Bank debate on paying for AIDS

 US$7.6 billion last year – unfair given various other health crises in the developing world. For example, in low-income countries in 2011, HIV/AIDS killed 72,000 people and ‘diarrheal diseases’ caused in part by unsanitary drinking water, led to 76,000 deaths. Yet more than half of US bilateral foreign assistance in health went to fighting the virus, compared with roughly an eighth to improvements in water and sanitation.  Read more

NIH reflects on the reality of an AIDS-free generation — updated

NIH reflects on the reality of an AIDS-free generation -- updated

After 22 years, the International AIDS Conference returns the US after a ban in 1992, intended to prevent HIV-infected people from entering the country, was lifted in 2010. This fact suits the optimistic tagline for the meeting, Turning the tide on the HIV epidemic, and Anthony Fauci, director of the NIH’s National Institute of Allergy and Infectious Diseases (NIAID) appeared jovial as he discussed the strides made since he attended the first meeting held in Atlanta, Georgia in 1985.  Read more

Proposed bill calls for better forensic science

Proposed bill calls for better forensic science

Investigators who linked DNA from Occupy Wall Street protesters to a murder scene in New York City recently admitted that they’d made a mistake. No one was locked behind bars, but all too often they are. A piece of legislation proposed yesterday seeks to end wrongful convictions through better forensic science.  Read more